Embecta Corp. Rings the Closing Bell
ABOUT THIS EVENT
Embecta Corp. (embecta) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, visits the Nasdaq MarketSite in Times Square.
embecta is the former diabetes care business of BD and generates $1.2B in annual revenue. embecta’s history in the diabetes care category dates back to 1924 and the development of the world's first specialized insulin syringe. Today, it is a leading producer of diabetes injection devices, manufacturing approximately 8 billion injection devices annually for about 30 million patients across more than 100 countries.
In honor of the occasion, Dev Kurdikar, CEO of embecta, the embecta leadership team and other key members of the organization ring the Closing Bell.